wpr-mega-menu-item-671 | Aspen Pharmacare

Aspen and SEMDSA highlight the alarming rise of non-communicable diseases on World Diabetes Day

November 13, 2024

Aspen and SEMDSA earlier today raised awareness around the alarming rise of non-communicable diseases, particularly diabetes, in recognition of World Diabetes Day.

Aspen to participate in the Investec CEO conference in London

November 13, 2024

Aspen’s Stephen Saad and Sean Capazorio will take part in Investec’s CEO conference in London from 14 to 15 November 2024.

Investor Relations

Investor Hub

Financial Information

Financial Results and Presentations

Integrated Reporting

Financial Calendar

SENS

Aspen and SEMDSA highlight the alarming rise of non-communicable diseases on World Diabetes Day

Aspen to participate in the Investec CEO conference in London

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023. The live presentation will take place in Cape Town at 08h30 on 2 March 2023.

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.